These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11989801)

  • 1. Erythro- and threo-2-hydroxynonyl substituted 2-phenyladenines and 2-phenyl-8-azaadenines: ligands for A1 adenosine receptors and adenosine deaminase.
    Biagi G; Giorgi I; Livi O; Pacchini F; Rum P; Scartoni V; Costa B; Mazzoni MR; Giusti L
    Farmaco; 2002 Mar; 57(3):221-33. PubMed ID: 11989801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N(6) or N(9) substituted 2-phenyl-8-azaadenines: affinity for A1 adenosine receptors. VII.
    Biagi G; Giorgi I; Livi O; Scartoni V; Breschi C; Martini C; Scatizzi R
    Farmaco; 1995 Oct; 50(10):659-67. PubMed ID: 8590573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of new N(6)-substituted 2-phenyl-8-azaadenosines. Their affinity for adenosine A1 and A2 receptors. A comparison with the corresponding 2-phenyl-9-benzyl-8-azaadenines. VI.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
    Farmaco; 1995 Jan; 50(1):13-9. PubMed ID: 7702716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New N6- or N(9)-hydroxyalkyl substituted 8-azaadenines or adenines as effective A1 adenosine receptor ligands.
    Biagi G; Giorgi I; Leonardi M; Livi O; Pacchini F; Scartoni V; Costa B; Lucacchini A
    Eur J Med Chem; 2003 Sep; 38(9):801-10. PubMed ID: 14561479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 2-(2'-phenyl-9'-benzyl-8'-azapurin-6'-ylamino)-carboxylic acid methylesters as ligands for A1 adenosine receptors.
    Biagi G; Giorgi I; Pacchini F; Livi O; Scartoni V
    Farmaco; 2001 Dec; 56(12):929-31. PubMed ID: 11829112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives. V.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
    Farmaco; 1994 Mar; 49(3):187-91. PubMed ID: 8043170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-cycloalkyl-2-phenyl-3-deaza-8-azaadenines: a new class of A1 adenosine receptor ligands. A comparison with the corresponding adenines and 8-azaadenines.
    Biagi G; Giorgi I; Livi O; Nardi A; Pacchini F; Scartoni V; Lucacchini A
    Eur J Med Chem; 2003; 38(11-12):983-90. PubMed ID: 14642330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals.
    Correia-de-Sá P; Ribeiro JA
    Neuroscience; 1996 Jul; 73(1):85-92. PubMed ID: 8783232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N(9)-Substituted 2-phenyl-N(6)-benzyl-8-azaadenines: A1 adenosine receptor affinity. A comparison with the corresponding N(6)-substituted 2-phenyl-N(9)-benzyl-8-azaadenines.
    Biagi G; Giorgi I; Livi O; Scartoni V
    Farmaco; 1996 Jun; 51(6):395-9. PubMed ID: 8845046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N(6)-substituted 2-N-butyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. IV.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
    Farmaco; 1994 Mar; 49(3):183-6. PubMed ID: 8043169
    [No Abstract]   [Full Text] [Related]  

  • 11. 2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies.
    Biagi G; Bianucci AM; Coi A; Costa B; Fabbrini L; Giorgi I; Livi O; Micco I; Pacchini F; Santini E; Leonardi M; Nofal FA; Salerni OL; Scartoni V
    Bioorg Med Chem; 2005 Aug; 13(15):4679-93. PubMed ID: 15908217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Aryl-8-azaadenosines: structure-activity relationships in the binding with A1 and A2 receptors. A comparison with the corresponding 9-benzyl-8-azaadenines. III.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
    Farmaco; 1994 Feb; 49(2):93-6. PubMed ID: 8003186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Cristalli G; Eleuteri A; Franchetti P; Grifantini M; Vittori S; Lupidi G
    J Med Chem; 1991 Mar; 34(3):1187-92. PubMed ID: 2002459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine.
    Harriman GC; Poirot AF; Abushanab E; Midgett RM; Stoeckler JD
    J Med Chem; 1992 Oct; 35(22):4180-4. PubMed ID: 1433220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R-nonyl)adenine [(+)-EHNA].
    Pragnacharyulu PV; Varkhedkar V; Curtis MA; Chang IF; Abushanab E
    J Med Chem; 2000 Nov; 43(24):4694-700. PubMed ID: 11101360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase inhibitors. Synthesis and biological evaluation of putative metabolites of (+)-erythro-9-(2S-hydroxy-3R-nonyl)adenine.
    Vargeese C; Sarma MS; Pragnacharyulu PV; Abushanab E; Li SY; Stoeckler JD
    J Med Chem; 1994 Oct; 37(22):3844-9. PubMed ID: 7966142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological activity and molecular modelling of new trisubstituted 8-azaadenines with high affinity for A1 adenosine receptors.
    Giorgi I; Bianucci AM; Biagi G; Livi O; Scartoni V; Leonardi M; Pietra D; Coi A; Massarelli I; Nofal FA; Fiamingo FL; Anastasi P; Giannini G
    Eur J Med Chem; 2007 Jan; 42(1):1-9. PubMed ID: 17028066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands.
    Giorgi I; Biagi G; Livi O; Leonardi M; Scartoni V; Pietra D
    Arch Pharm (Weinheim); 2007 Feb; 340(2):81-7. PubMed ID: 17294400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of substituent size upon adenosine receptor A1/A2 affinity of some newly synthesised 8-cycloalkyl xanthines.
    Castagnino E; Salvatori A; Corsano S; Tacchi P; Martini C; Lucacchini A
    Drug Des Discov; 1995 Apr; 12(4):313-21. PubMed ID: 9040991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE; Geis U; Grahner B; Lanzner W; Eger K
    J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.